Drug profile · INN
mebutamate
DORMATE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
mebutamate (DORMATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN mebutamate
Brand DORMATE
Route ORAL
Formulation TABLET
Frequently asked questions
What is mebutamate?
mebutamate (DORMATE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mebutamate?
DORMATE is a marketed brand name for mebutamate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mebutamate?
mebutamate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.